Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04
  • S Tag Peptide: Reliable Fusion Tag for Protein Solubility...

    2026-02-14

    S Tag Peptide: Reliable Fusion Tag for Protein Solubility and Detection

    Executive Summary: The S Tag Peptide (SKU A6007) is a synthetic 15-amino acid peptide derived from the N-terminus of pancreatic ribonuclease A, frequently used as a protein fusion tag. It enhances recombinant protein solubility through its charged and polar sequence, does not form a distinct structure independently, and can be fused to either protein terminus for detection and purification workflows (APExBIO). Commercial anti-S-Tag antibodies enable sensitive detection in formats such as western blotting and immunoprecipitation (Miyoshi et al. 2021). S Tag Peptide exhibits high solubility in DMSO (≥174.9 mg/mL) and water (≥50 mg/mL), and is stored desiccated at -20°C to preserve integrity. Its role as a protein solubility enhancer and a reliable antibody epitope is supported by peer-reviewed evidence and validated product data.

    Biological Rationale

    The development of fusion tags is fundamental in recombinant protein expression and purification. The S Tag Peptide was derived from the S-peptide region of ribonuclease S, a cleavage product of pancreatic ribonuclease A, which retains activity when bound to its complementary fragment (Miyoshi et al. 2021). Unlike large affinity tags, the S Tag minimizes structural interference and proteolytic susceptibility. Its length (15 amino acids) is short enough to limit steric hindrance, yet sufficient to support high-affinity antibody recognition (see this mechanistic overview), extending beyond the scope of earlier reviews by focusing on antibody kinetics and detection reliability. The S Tag sequence (H-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Phe-Glu-Arg-Gln-His-Met-Asp-Ser-OH) is rich in charged (Lys, Glu, Arg, Asp) and polar residues (Thr, Gln, His, Ser), which collectively enhance the solubility of tagged proteins in aqueous solutions. This property is leveraged in molecular biology for the efficient production and downstream analysis of otherwise aggregation-prone recombinant proteins.

    Mechanism of Action of S Tag Peptide

    S Tag Peptide functions by covalent genetic fusion to the N- or C-terminus of a target protein, enabling its co-expression and purification. The peptide itself remains unstructured in isolation, preventing the formation of obstructive secondary or tertiary structures (see solubility enhancer details). Upon expression, the S Tag increases solubility through its hydrophilic, charge-rich amino acid sequence, reducing aggregation. For detection, anti-S-Tag antibodies bind specifically to the tag, enabling versatile applications such as western blotting, immunoprecipitation, and single-molecule imaging (Miyoshi et al. 2021). The peptide is not immunogenic in most contexts and can be removed post-purification if desired. In contrast to larger affinity tags, S Tag fusion does not significantly perturb folding or function of the target protein, provided that fusion junctions are selected to avoid functional domains (see workflow guidance).

    Evidence & Benchmarks

    • S Tag Peptide enables fast, specific detection of fusion proteins using monoclonal anti-S-Tag antibodies, with antibody dissociation half-lives of 0.98–2.2 seconds in single-molecule TIRF assays (DOI:10.1016/j.celrep.2021.108708).
    • S Tag fusion increases solubility of typically aggregation-prone proteins in aqueous buffer (pH 7.4, 4°C), as measured by soluble fraction yield in recombinant expression (epitopepeptide.com).
    • No significant structural perturbation or enzymatic inhibition is observed for most target proteins when fused to S Tag, validated through enzymatic activity assays (flagpeptide.com).
    • Solutions of S Tag Peptide remain stable for immediate use when dissolved in DMSO (≥174.9 mg/mL) or water (≥50 mg/mL), but rapid degradation occurs at room temperature over 48 hours (APExBIO product page).
    • Anti-S-Tag antibody detection is compatible with advanced imaging (dual-view inverted selective plane illumination microscopy, diSPIM), as demonstrated in multiplex immunoassays (DOI:10.1016/j.celrep.2021.108708).

    Applications, Limits & Misconceptions

    Primary applications: S Tag Peptide is employed as a fusion partner for recombinant protein production, facilitating purification, detection, and imaging. It serves as a solubility enhancer for aggregation-prone proteins and as an epitope for commercial anti-S-Tag antibody binding (S Tag Peptide product). Its use extends to western blotting, immunoprecipitation, enzyme-linked immunosorbent assays, and high-resolution microscopy (Miyoshi et al. 2021).

    Limits: The S Tag does not confer affinity purification properties on its own, unlike some larger tags (e.g., His6, FLAG). Its detection depends on the availability of high-affinity anti-S-Tag antibodies. The tag may interfere with function or localization if fused within functional protein domains. It is not recommended for long-term storage in solution due to susceptibility to degradation (APExBIO).

    Common Pitfalls or Misconceptions

    • Misconception: S Tag Peptide enables direct affinity purification.
      Clarification: S Tag is an epitope tag, not an affinity tag; additional purification handles (e.g., His6) are needed for direct chromatography (mechanistic basis).
    • Misconception: S Tag fusion always increases expression yields.
      Clarification: While it improves solubility, total expression depends on other vector and host cell factors (workflow troubleshooting).
    • Pitfall: Long-term storage of dissolved peptide.
      Clarification: S Tag Peptide should be stored dry at -20°C; solutions are unstable and prone to hydrolysis.
    • Misconception: S Tag is immunogenic in mammalian cell systems.
      Clarification: No significant immunogenicity has been reported in standard eukaryotic expression workflows (Miyoshi et al. 2021).
    • Pitfall: Using anti-S-Tag antibodies with suboptimal affinity or specificity.
      Clarification: Benchmark antibody clones should be selected for consistent detection (Miyoshi et al. 2021).

    Workflow Integration & Parameters

    S Tag Peptide is typically introduced at the genetic level via plasmid constructs, fused to either terminus of the target gene using standard molecular cloning techniques. Expression is performed in E. coli, yeast, or mammalian systems under optimized conditions (e.g., 37°C, IPTG induction, pH 7.4). Post-expression, the fusion protein is extracted and can be detected with anti-S-Tag antibodies in western blots, ELISAs, or immunoprecipitation. For imaging, fluorescently labeled Fab fragments derived from anti-S-Tag monoclonal antibodies are used for single-molecule or super-resolution microscopy (Miyoshi et al. 2021). Storage recommendations include lyophilization and desiccation at -20°C; freshly prepared solutions should be used immediately to prevent degradation (APExBIO).

    For scenario-based strategies and troubleshooting, see this guide, which this review updates with benchmarks from recent single-molecule antibody studies and quantitative stability data.

    Conclusion & Outlook

    The S Tag Peptide (A6007) from APExBIO is a validated, versatile protein fusion tag that enhances solubility, enables robust antibody-based detection, and integrates seamlessly into modern protein expression workflows. Its small size and hydrophilic sequence minimize structural disruption while supporting sensitive, multiplexed analysis. Recent advances in monoclonal antibody screening and single-molecule imaging have expanded its utility, confirming the S Tag as a foundational tool for reproducible molecular biology. For detailed protocols and extended use-cases, refer to the S Tag Peptide product page and supplementary application notes. This article clarifies and extends prior resources by anchoring claims to peer-reviewed evidence and standardized benchmarks.